A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents-Reference-Cited by-同舟云学术

A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescents

Published:2010-09-06 Issue:6 Volume:46 Page:790-799
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Styczynski J,Tallamy B,Waxman I,van de Ven C,Milone M C,Shaw L M,Harrison L,Morris E,Satwani P,Bhatia M,George D,Bradley M B,Garvin J H,Schwartz J,Baxter-Lowe L A,Cairo M S

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2010209.pdf

Reference33 articles.

1. Ciurea SO, Andersson BS . Busulfan in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 523–536.

2. Satwani P, Harrison L, Morris E, Del Toro G, Cairo MS . Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges. Biol Blood Marrow Transplant 2005; 11: 403–422.

3. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756–763.

4. Del Toro G, Satwani P, Harrison L, Cheung YK, Brigid Bradley M, George D et al. A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplant 2004; 33: 613–622.

5. Jacobsohn DA, Duerst R, Tse W, Kletzel M . Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children. Lancet 2004; 364: 156–162.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Strategies for Enhancing the Efficacy of CAR T-Cell Therapy for Hematological Malignancies;Cancers;2022-09-14

2. Worked to the bone: antibody-based conditioning as the future of transplant biology;Journal of Hematology & Oncology;2022-05-19

3. Evaluation of a Nanoparticle-Based Busulfan Immunoassay for Rapid Analysis on Routine Clinical Analyzers;Therapeutic Drug Monitoring;2021-12

4. Reduced Toxicity Conditioning for Nonmalignant Hematopoietic Cell Transplants;Biology of Blood and Marrow Transplantation;2020-09

5. A phase I study of CAR‑T bridging HSCT in patients with acute CD19⁺ relapse/refractory B‑cell leukemia;Oncology Letters;2020-07-16